Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

BACKGROUND: Available evidence suggests that adjunctive treatment with immunomodulatory medications may be effective in the treatment of major depressive disorder (MDD). A pilot trial of the tetracycline minocycline as adjunctive treatment in treatment-resistant depression (TRD), produced promising...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Psychiatry
Autori principali: Husain, Muhammad Ishrat, Cullen, Clare, Umer, Madeha, Carvalho, Andre F., Kloiber, Stefan, Meyer, Jeffrey H., Ortiz, Abigail, Knyahnytska, Yuliya, Husain, M. Omair, Giddens, Justine, Diniz, Breno S., Wang, Wei, Young, Allan H., Mulsant, Benoit H., Daskalakis, Zafiris J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Study Protocol
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7161279/
https://ncbi.nlm.nih.gov/pubmed/32295565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-020-02553-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi